Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
7
×
Tags
life sciences
national blog main
7
×
new york blog main
7
×
san francisco blog main
boston blog main
clinical trials
national top stories
new york top stories
san francisco top stories
biotech
boston top stories
san diego blog main
bristol-myers squibb
gene therapy
san diego top stories
amgen
boulder/denver blog main
clinical data
drugs
glaxosmithkline
merck
national
new york
pfizer
raleigh-durham blog main
raleigh-durham top stories
roche
san francisco
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
23andme
acadia pharmaceuticals
adverum biotechnologies
aimmune
alirocumab
alk
What
data
7
×
drug
medical
new
cancer
long
lung
medicines
adds
advanced
ago
alnylam
analyzes
annual
approved
arrival
award
based
bio
biotechs
breast
cancer's
ceo
cholesterol
clinical
close
company
conference
considering
death
decades
dems
developing
devices
disease
diseases
drugs
dyne
early
electronic
Language
unset
Current search:
photo
×
" national blog main "
×
" new york blog main "
×
data
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO